INLYTA 5 mg/1 5 mg/1 TABLET, FILM COATED

INLYTA 5 mg/1

Active Ingredient:
axitinib
Form:
TABLET, FILM COATED
Brand:
INLYTA
Origin:
USA

Buy INLYTA 5 mg/1 axitinib

INLYTA 5 mg tablets are a pharmaceutical product used for specific medical conditions. This oral medication is designed to support targeted therapy, offering a convenient film-coated tablet form for consistent dosing.

Strength

5 mg/1

Pack Size

60 TABLET, FILM COATED in 1 BOTTLE (0069-0151-11)

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Uses / Indications

  • INLYTA 5 mg tablets are primarily used in the management of certain types of advanced renal cell carcinoma, a form of kidney cancer. This medication is often prescribed as part of a broader treatment plan, aiming to inhibit the growth and spread of cancer cells. Patients and healthcare providers may explore 'what is INLYTA used for' to understand its role in targeted therapy.

Side Effects

  • Common effects of INLYTA 5 mg tablets may include fatigue, diarrhea, and high blood pressure. Some users might experience decreased appetite or nausea. These effects can vary among individuals, and it's important to monitor any changes in health while using this medication.

Precautions & Warnings

  • INLYTA 5 mg tablets should be handled with care, stored properly, and used exactly as directed. Patients should avoid crushing or chewing the tablets to maintain their effectiveness. It's crucial to follow the advice of a healthcare professional regarding the use of this medication.

Avoid Interactions

  • INLYTA 5 mg tablets may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements, to avoid potential interactions.

References

Frequently Asked Questions

INLYTA is used in the treatment of advanced renal cell carcinoma, a type of kidney cancer. It is part of a targeted therapy approach.

INLYTA tablets should be taken orally, with or without food, as directed by a healthcare provider. They should not be crushed or chewed.

Common side effects may include fatigue, diarrhea, high blood pressure, decreased appetite, and nausea.

INLYTA may interact with other medications, especially those metabolized by the liver's CYP3A4 enzyme. Always consult a healthcare provider before combining medications.

INLYTA should be stored at room temperature, away from moisture and heat, and kept out of reach of children.

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT